Ejaculation Clinical Trial
Official title:
A Phase 2b, Multi-Centre, Double-Blind, Placebo-Controlled, Parallel Group Dose Response Study To Assess The Efficacy and Safety Of Oral UK390,957 In Men With Premature Ejaculation
Assessment of efficacy and safety UK-390,957.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01021670 -
An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride
|
Phase 4 | |
| Completed |
NCT00210613 -
A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation
|
Phase 3 | |
| Completed |
NCT00211107 -
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
|
Phase 3 | |
| Completed |
NCT00219635 -
Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation
|
Phase 2/Phase 3 | |
| Completed |
NCT00219609 -
Assessment Of Safety Of UK-390,957
|
Phase 2/Phase 3 | |
| Terminated |
NCT02918227 -
Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia
|
N/A | |
| Completed |
NCT00143117 -
Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation
|
Phase 2/Phase 3 | |
| Completed |
NCT01366664 -
A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin
|
Phase 1 | |
| Completed |
NCT00211094 -
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
|
Phase 3 | |
| Completed |
NCT01230762 -
An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation
|
Phase 3 |